CEL-SCI

About:

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

Website: http://www.cel-sci.com

Twitter/X: CelSciCorp

Top Investors: Iroquois Capital, Alpha Capital, Aegis Capital Corporation, Paramount BioCapital Asset Management, ArmaVir Partners

Description:

CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.

Total Funding Amount:

$86M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vienna, Virginia, United States

Founded Date:

1983-01-01

Contact Email:

Feedback(AT)cel-sci.com

Founders:

Maximilian de Clara

Number of Employees:

11-50

Last Funding Date:

2024-07-26

IPO Status:

Public

Industries:

© 2025 bioDAO.ai